- Home
- NAUT vs IAF Comparison
NAUT vs IAF Comparison
Compare NAUT & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- IAF
- Stock Information
- Founded
- NAUT 2016
- IAF 1985
- Country
- NAUT United States
- IAF United States
- Employees
- NAUT N/A
- IAF N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- IAF Finance/Investors Services
- Sector
- NAUT Industrials
- IAF Finance
- Exchange
- NAUT Nasdaq
- IAF Nasdaq
- Market Cap
- NAUT 104.7M
- IAF 124.2M
- IPO Year
- NAUT N/A
- IAF N/A
- Fundamental
- Price
- NAUT $1.41
- IAF $13.39
- Analyst Decision
- NAUT Strong Sell
- IAF
- Analyst Count
- NAUT 1
- IAF 0
- Target Price
- NAUT $1.75
- IAF N/A
- AVG Volume (30 Days)
- NAUT 613.3K
- IAF 90.4K
- Earning Date
- NAUT 10-28-2025
- IAF 01-01-0001
- Dividend Yield
- NAUT N/A
- IAF 11.44%
- EPS Growth
- NAUT N/A
- IAF N/A
- EPS
- NAUT N/A
- IAF N/A
- Revenue
- NAUT N/A
- IAF N/A
- Revenue This Year
- NAUT N/A
- IAF N/A
- Revenue Next Year
- NAUT N/A
- IAF N/A
- P/E Ratio
- NAUT N/A
- IAF N/A
- Revenue Growth
- NAUT N/A
- IAF N/A
- 52 Week Low
- NAUT $0.62
- IAF $3.60
- 52 Week High
- NAUT $2.92
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- NAUT 63.95
- IAF 96.33
- Support Level
- NAUT $1.21
- IAF $4.54
- Resistance Level
- NAUT $1.52
- IAF $14.15
- Average True Range (ATR)
- NAUT 0.18
- IAF 0.79
- MACD
- NAUT 0.03
- IAF 1.11
- Stochastic Oscillator
- NAUT 77.34
- IAF 95.86
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.